Welcome. Check out other companies controlled by warren Lichtenstein. Not many people who own shares in an entity controlled by him have made money. SXCL HNH SPLP MLNK. Your investment thesis on this one is an old one. Good luck. Maybe your timing will prove correct.
before going dark I thought this was going to 11, Now I think 7 or 8. oil service companies will burn cash and probably file BK. WL will prob figure out how to sweep most of the cash to SPLP.
I don't think it will double in value with its current collection of companies unless the price of oil doubles.
Splp owns around 50% of sxcl. They are essentially a controlling shareholder. You can't make them do anything they don't want to do.
Any activist campaign will most likely be a waste of time and money- Especially one coming from a bank that owns 2 percent of the company.
with all that said, I have decided to buy some shares around here. The rationale is that the company is trading right around net cash levels. I think it could trade lower, however, I think the upside is if WL uses this entity to consolidate some of the other companies into this entity. It has a high amount of NOL's and if he is every able to build a profitable business over time, this could be of value.
Well, here we are at $12. I thought we could hit 12 with the assumption that the oil services companies file BK. That's looking increasingly likely which leaves SXCL with a near 100% success rate on running every company acquired in the last few years into BK. WL and SPLP is still charging SXCL $8 million a year (if my memory is correct) to provide management services. The stock probably trades to $10. The only upside is if WL uses SXCL as a vehicle to consolidate some other holdings like HNH.
how do you value the company? I think around $11. That's where I think it trades.
that's also why I think Howard sold a half million around $22 15 days before the third quarter ended.
I guess he's a lucky seller. Probably not because he knew things were going to be this bad 83% through the 3rd quarter. nah. I guess he thinks the risk of selling then was worth it.
Not sure what can be done- they control the companies and they make public disclosures. All disclosures seem fine. The only thing I have questioned is the timing of Howards recent sales of SXCL. They have a similar track record at other companies they control. A few years ago management was owed a performance fee. They converted that amount into stock at $12 a share for SPLP, after watching it drop from 17. after that fee converted into shares at 12, they announced a stock buyback which helped drive the stock back up. Then whey they reported their annual performance in the SPLP annual report, they excluded the loss of the stock dropping from 17 to 12 due to an illiquid market. However, they took credit for the SPLP gains from 12 back to 17. Check out all the asterisks in that report. For somer eason, they have SXCL using its cash to buy SPLP stock in the open market. Doesn't make sense to me. HNH: after the stock dropped from 47 to 30, they had HNH buy a company that SPLP owned a percentage of. They converted their stock into HNH at half the value it was trading a few months before.
It's more like a $12 stock. Many of the companies they bought have been shut down. The oil service companies EBTIDA is heading towards zero. They spent about $200 million buying them. Most of the public company investments have been poor as well. SP Corporate services is charging SXCL about $9 million a year for all this. And on top of it, Howard sold a bunch of stock around $22 about 15 days before the end of the 3rd quarter ended. 3rd quarter earnings were very bad. I can't imagine that he wasn't aware of that information when he sold. I've learned that I don't want to be a minority shareholder along side WL and Co.
It's been a while since I looked into the patent positioning, but my recollection is that Biomarin has superior patent positioning with respect to exon 51, and maybe even more broadly.
Can Sarepta sell the drug outside the US without a legal fight with BMRN?
I always thought the reason why BMRN bought Prosena was for the patent portfolio. Even if they didn't get drisipearson approved, they could potentially get royalties from SRPT.
Anyone have thoughts on this?